Interactive map of fiscal 2011 FDA cGMP warning letters

By Nick Taylor

- Last updated on GMT

Related tags Food and drug administration Europe Fda

Interactive map of fiscal 2011 FDA cGMP warning letters
In-PharmaTechnologist presents an interactive map showing the global distribution of US FDA cGMP warning letters in fiscal 2011.

As reported earlier this week, the US Food and Drug Administration (FDA) continued to crackdown on overseas manufacturing plants last fiscal year with a 40 per cent increase in warning letters.

Sites in Mexico and India accounted for one-third of overseas production plants cited in FDA cGMP (current good manufacturing practice) warning letters last year. The map below shows the sites of these production plants and every other facility named by the FDA in fiscal 2011 warning letters.

North America and Western Europe account for many of the warning letters. For the first time since 2009 the FDA sent no warning letters to facilities in South America, leaving India and China as the emerging market hotbeds of regulatory enforcement actions.

View Warning Letters 2011 in a larger map

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Related suppliers

Follow us


View more